Yoga as Adjunct Therapy for Chronic Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Avicenna Journal of Medicine Pub Date : 2023-09-22 eCollection Date: 2023-07-01 DOI:10.1055/s-0043-1774738
Abhijit Dutta, Aruchunan Mooventhan, L Nivethitha
{"title":"Yoga as Adjunct Therapy for Chronic Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.","authors":"Abhijit Dutta,&nbsp;Aruchunan Mooventhan,&nbsp;L Nivethitha","doi":"10.1055/s-0043-1774738","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>  Chronic heart failure (CHF) is a prevalent cardiovascular condition that can significantly impact the quality of life and increase mortality risk. Yoga is a mind-body therapy that has been studied as a potential complementary treatment for CHF. However, the effectiveness of yoga in improving outcomes in patients with CHF remains uncertain. <b>Methods</b>  We conducted a systematic review of randomized controlled trials (RCTs) evaluating the effects of yoga on outcomes in patients with CHF. We searched the PubMed, Embase, Scopus, Cochrane Library, and IndMED databases from inception to March 2023. The outcomes of interest were left ventricular ejection fraction (LVEF), cardiac biomarkers, exercise capacity, quality of life, and cardiac function. <b>Results</b>  We identified 11 RCTs that met our inclusion criteria, involving a total of 552 participants. The meta-analysis showed that yoga was associated with significant improvements in peak VO <sub>2</sub> (mean difference [MD]= 3.29; 95% Confidence Interval [CI]: 1.64 to 4.94; I <sup>2</sup> = 0%), exercise capacity (MD=101.54; 95% CI: 6.24 to 196.83; I <sup>2</sup> = 96%), quality of life (MD = -19.99; 95% CI: -25.76 to -14.22; <i>I</i> <sup>2</sup>  = 43%), NT-proBNP (MD = -288.78; 95% CI: -492.20 to -85.37; <i>I</i> <sup>2</sup>  = 94%), and 6-minute walk test (MD = 101.54; 95% CI: 6.24-196.83; <i>I</i> <sup>2</sup>  = 96%), but not in the left ventricular ejection fraction (MD = 4.28; 95% CI: -1.14 to 9.70; <i>I</i> <sup>2</sup>  = 93%). Subgroup analysis suggested that the effect of yoga on the quality of life is more pronounced in patients with the \"New York Heart Association\" (NYHA) class I and II CHF patients and in those who practiced yoga for longer durations. No serious adverse events related to yoga were reported. Most of the included studies were of \"low\" quality. <b>Conclusion</b>  Current evidence suggests that yoga may be an effective complementary and integrative therapy for improving peak VO <sub>2</sub> exercise capacity, NT-proBNP, and quality of life in patients with CHF. However, the low-quality evidence does not render us to conclude anything beyond doubt or draw any firm clinical recommendation. Future high-quality studies are needed to explore the optimal duration and frequency of yoga practice and its effects on long-term outcomes in this population.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550367/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Avicenna Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1774738","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background  Chronic heart failure (CHF) is a prevalent cardiovascular condition that can significantly impact the quality of life and increase mortality risk. Yoga is a mind-body therapy that has been studied as a potential complementary treatment for CHF. However, the effectiveness of yoga in improving outcomes in patients with CHF remains uncertain. Methods  We conducted a systematic review of randomized controlled trials (RCTs) evaluating the effects of yoga on outcomes in patients with CHF. We searched the PubMed, Embase, Scopus, Cochrane Library, and IndMED databases from inception to March 2023. The outcomes of interest were left ventricular ejection fraction (LVEF), cardiac biomarkers, exercise capacity, quality of life, and cardiac function. Results  We identified 11 RCTs that met our inclusion criteria, involving a total of 552 participants. The meta-analysis showed that yoga was associated with significant improvements in peak VO 2 (mean difference [MD]= 3.29; 95% Confidence Interval [CI]: 1.64 to 4.94; I 2 = 0%), exercise capacity (MD=101.54; 95% CI: 6.24 to 196.83; I 2 = 96%), quality of life (MD = -19.99; 95% CI: -25.76 to -14.22; I 2  = 43%), NT-proBNP (MD = -288.78; 95% CI: -492.20 to -85.37; I 2  = 94%), and 6-minute walk test (MD = 101.54; 95% CI: 6.24-196.83; I 2  = 96%), but not in the left ventricular ejection fraction (MD = 4.28; 95% CI: -1.14 to 9.70; I 2  = 93%). Subgroup analysis suggested that the effect of yoga on the quality of life is more pronounced in patients with the "New York Heart Association" (NYHA) class I and II CHF patients and in those who practiced yoga for longer durations. No serious adverse events related to yoga were reported. Most of the included studies were of "low" quality. Conclusion  Current evidence suggests that yoga may be an effective complementary and integrative therapy for improving peak VO 2 exercise capacity, NT-proBNP, and quality of life in patients with CHF. However, the low-quality evidence does not render us to conclude anything beyond doubt or draw any firm clinical recommendation. Future high-quality studies are needed to explore the optimal duration and frequency of yoga practice and its effects on long-term outcomes in this population.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
瑜伽作为慢性心力衰竭的辅助治疗:随机对照试验的系统综述和荟萃分析。
背景 慢性心力衰竭(CHF)是一种常见的心血管疾病,会显著影响生活质量并增加死亡率。瑜伽是一种身心疗法,已被研究为CHF的潜在补充疗法。然而,瑜伽在改善CHF患者预后方面的有效性仍不确定。方法 我们对随机对照试验(RCT)进行了系统回顾,评估瑜伽对CHF患者预后的影响。从成立到2023年3月,我们搜索了PubMed、Embase、Scopus、Cochrane Library和IndMED数据库。感兴趣的结果是左心室射血分数(LVEF)、心脏生物标志物、运动能力、生活质量和心脏功能。后果 我们确定了11项符合纳入标准的随机对照试验,共涉及552名参与者。荟萃分析显示,瑜伽与峰值VO2(平均差[MD]=3.29;95%置信区间[CI]:1.64至4.94;I2=0%)、运动能力(MD=101.54;95%CI:6.24至196.83;I2=96%)、生活质量(MD = -19.99;95%可信区间:-25.76至-14.22;I 2 = 43%)、NT-proBNP(MD = -288.78;95%可信区间:-492.20~-85.37;I 2 = 94%)和6分钟步行测试(MD = 101.54;95%置信区间:6.24-196.83;I 2 = 96%),但在左心室射血分数(MD)中没有 = 4.28;95%可信区间:-1.14~9.70;I 2 = 93%)。亚组分析表明,瑜伽对生活质量的影响在“纽约心脏协会”(NYHA)I级和II级CHF患者以及长期练习瑜伽的患者中更为明显。未报告与瑜伽相关的严重不良事件。大多数纳入的研究质量“低”。结论 目前的证据表明,瑜伽可能是一种有效的补充和综合疗法,可以改善CHF患者的峰值VO2运动能力、NT-proBNP和生活质量。然而,低质量的证据并不能使我们得出任何毫无疑问的结论或得出任何坚定的临床建议。未来需要进行高质量的研究,以探索瑜伽练习的最佳持续时间和频率及其对该人群长期结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
28
审稿时长
26 weeks
期刊最新文献
Clearing the Skepticism about Subclinical Hypothyroidism: Is It Beneficial to Treat Patients with Thyroid-Stimulating Hormone >4.5 and <10 mIU/L? Investigation of Correlation between Communication Skills and Self-Reported Elder Mistreatment in Family Abuse. Burden of Chronic Hemodialysis on the Ability to Work: Time for Action. Rheumatic Diseases Amidst Conflict in Northwest Syria: Unveiling Health Challenges and Implications Renal Cell Carcinoma Metastasizing to Oral Soft Tissues: Systematic Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1